Synopsis

Wilms tumour (WT) is the second most common abdominal tumour in children. It has an excellent prognosis with a 5-year survival close to 90%. Nevertheless, the story is not finished, as we have to understand why 10% of children continue to have a poor prognosis. Furthermore, the long term follow-up of the survivors shows that they have significant side effects (renal, cardiovascular, second malignancy) related to their treatment (radiotherapy, surgery) or to their underlying condition. During this Grand Round, we will present the challenges we face currently in the management of children with WT and the strategies to close the gaps.

Speakers

Professor Yves Heloury is a Paediatric Urologist at The Royal Children’s Hospital. He is Professor of Paediatric Surgery in France, in delegation in Australia. Yves is a Fellow of the European Academy of Paediatric Urology and Fellow of the Royal Australasia College of Surgeons.  He is the Medical Director of the Victorian Paediatric Integrated Cancer Services which is the Victorian network for paediatric oncology.  Yves is a co-author of more than one hundred and ten referenced papers with a special interest in laparoscopy and oncology.

Dr Marty Campbell is a Paediatric Oncologist at The Royal Children’s Hospital and Chair of the Solid Tumour Combined Therapy Clinic for RCH and Monash Medical Centre.  Marty is a Fellow of The Royal Australasian College of Physicians and a member of The Children’s Oncology Group and the Renal Tumour Study Group of the International Society of Paediatric Oncology. He is also a member of the Solid Tumour subgroup of The Australian and New Zealand Children’s Haematology and Oncology Group and has a special interest in Wilms tumour.